ValoreQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMFlussi di cassa derivanti dalle attività di investimento-69 K-32 K-135 K-24 K-101 K5.25 M4.99 MLiquidità derivante dalle attività di finanziamento3.75 M3.1 M3.74 M148 K-80 K-2.29 M1.52 MLiquidità libera8.58 M7.88 M1.25 M3.69 M679 K-1.19 M4.43 M
Niagen Bioscience, Inc. - Common Stock
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ.